CLASS I Drug recall · Reported 15 Jun 2016 · FDA Enforcement Report

Dextrose Injection,USP,70% Viaflex, Pharmacy recalled

Baxter Healthcare is recalling Dextrose Injection,USP,70% Viaflex, Pharmacy , Not For Direct Infusion, Must Be Diluted, distributed nationwide in the US. The recall was initiated on 15 Dec 2015 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesLot # C985150; Exp. 07/16

NDC0338-0719

Quantity recalled28,080 VIAFLEX Plastic Containers

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number: D-0958-2016
FDA event ID: 72816
Recalling firm: Baxter Healthcare, Deerfield, IL
Brand: Dextrose
Manufacturer: Baxter Healthcare Corporation
Classification: Class I
Status: Terminated
Recall initiated: 15 Dec 2015
FDA classified: 6 Jun 2016
Reported: 15 Jun 2016
Type: Voluntary: Firm initiated
Customers notified by: Letter
Reason category: Particulate Matter
Drug class: Injectable & IV Drugs

Timeline

15 Dec 2015	Recall initiated by company
6 Jun 2016	Classified by FDA	+174 days
15 Jun 2016	Published in enforcement report	+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Presence of Particulate Matter: Confirmed customer compliants of finding an insect floating in the primary container of each product.

Product as listed by the FDA

Dextrose Injection,USP,70% 2000 mL VIAFLEX Plastic Container Bag, Pharmacy Bulk Package, Not For Direct Infusion, Must Be Diluted, Rx Only, Manufactured by Baxter Healthcare Corporation, Deerfield, IL 60015, NDC 0338-0719-06

Where it was distributed

Nationwide

Questions about this recall

Why was it recalled?

Presence of Particulate Matter: Confirmed customer compliants of finding an insect floating in the primary container of each product.

Which lots are affected?

Lot # C985150; Exp. 07/16

Where was it sold?

Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 72816

This product is part of a recall event; the main page for the event is 0.9% Sodium Chloride Injection, USP Viaflex recalled.

Reported	Class	Recall	Company	Reason	Where
15 Jun 2016	CLASS I	0.9% Sodium Chloride Injection, USP Viaflex recalledSodium Chloride	Baxter Healthcare	Particulate Matter	Nationwide

More recalls from Baxter Healthcare

All 565

Reported	Class	Recall	Company	Reason	Where
16 Sep 2026Drug	CLASS I	Dextrose Injection, USP, 70 % recalled by Baxter Healthcare	Baxter Healthcare	Particulate Matter	Nationwide
9 Sep 2026Drug	CLASS I	0.9% Sodium Chloride Injection USP, Viaflex recalledSodium Chloride	Baxter Healthcare	Particulate Matter	IL
9 Sep 2026Device	CLASS II	Baxter Novum IQ Syringe Pump, Loaner recalled by Baxter Healthcare	Baxter Healthcare	Device Malfunction	Nationwide
9 Sep 2026Device	CLASS II	Baxter Novum IQ Syringe Pump recalled by Baxter Healthcare	Baxter Healthcare	Device Malfunction	Nationwide
9 Sep 2026Drug	CLASS II	Clindamycin Phosphate in 0.9% Sodium Chloride Injection recalledClindamycin Phosphate	Baxter Healthcare	Manufacturing (CGMP) Deviations	Nationwide

Other Dextrose recalls

All 43

Reported	Class	Recall	Company	Reason	Where
16 Sep 2026Drug	CLASS I	Dextrose Injection, USP, 70 % recalled by Baxter Healthcare	Baxter Healthcare	Particulate Matter	Nationwide
29 Apr 2026Drug	CLASS II	Dextrose Injection recalled by B Braun MedicalDextrose	B Braun Medical	Sterility	Nationwide
15 Apr 2026Drug	CLASS II	5% Dextrose Injection, USP per (50 mg per mL) in a freeflex recalledDextrose	Fresenius Kabi USA	Sterility	Nationwide
15 Apr 2026Drug	CLASS II	5% Dextrose Injection, USP per (50 mg per mL) in a freeflex recalledDextrose	Fresenius Kabi USA	Sterility	Nationwide
15 Apr 2026Drug	CLASS II	5% Dextrose Injection, USP per (50 mg per mL) in a freeflex recalledDextrose	Fresenius Kabi USA	Sterility	Nationwide